Welcome message from the Director-General / CEO
The National Institute for Pharmaceutical Research and Development (NIPRD) is a Federal Government Parastatal under the Federal Ministry of Health. The Agency was established by Government Order No. 33 Vol. 74 of 11th June 1987 Part B under the Science and Technology Act Cap 276. It became functional in the year 1989. In 2001 following a Federal Executive Council decision, NIPRD was moved to the Federal Ministry of Health (FMOH), with a huge investment in scientific equipment and human resources.
NIPRD is the only one of its kind in the Region, and is statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines, commodities, and diagnostics aimed at improving sustainable access to safe, affordable and high-quality healthcare. Read more…
NSP-II and M&E Plan (2021 - 2025)
Follow NIPRD on TwitterMy Tweets
ASICC-19 Opening Presidential Statement Opening – 18th October, 2021 Nigeria Has What It Takes To Become A Leader In Healthcare, Says Osinbajo Know more… Nigeria,
Webinar Conference (Series 3.0) on “Improving Access to COVID-19 Vaccines and other Interventions: Intellectual Property, Patent Waivers and other Critical Factors” PRESS RELEASES
Express Day Nigeria can lead vaccines production in Africa- NIPRD DG Independent Nigeria Can Lead Vaccines Production In Africa – NIPRD DG Vanguard With right